We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems (VEEV) Rises Higher Than Market: Key Facts
Read MoreHide Full Article
Veeva Systems (VEEV - Free Report) closed at $316.80 in the latest trading session, marking a +2.08% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.41% for the day. Elsewhere, the Dow lost 0.07%, while the tech-heavy Nasdaq added 1.11%.
Shares of the provider of cloud-based software services for the life sciences industry witnessed a gain of 19.27% over the previous month, beating the performance of the Medical sector with its gain of 1.97%, and the S&P 500's gain of 1.46%.
Analysts and investors alike will be keeping a close eye on the performance of Veeva Systems in its upcoming earnings disclosure. In that report, analysts expect Veeva Systems to post earnings of $2.33 per share. This would mark year-over-year growth of 14.22%. Our most recent consensus estimate is calling for quarterly revenue of $933.79 million, up 15.11% from the year-ago period.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $9.22 per share and revenue of $3.69 billion. These totals would mark changes of +13.83% and +15.35%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Veeva Systems. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Veeva Systems is currently sporting a Zacks Rank of #3 (Hold).
Looking at valuation, Veeva Systems is presently trading at a Forward P/E ratio of 33.67. This expresses a premium compared to the average Forward P/E of 32.9 of its industry.
Meanwhile, VEEV's PEG ratio is currently 0.96. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The average PEG ratio for the Medical Info Systems industry stood at 3.08 at the close of the market yesterday.
The Medical Info Systems industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 96, finds itself in the top 40% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
Veeva Systems (VEEV) Rises Higher Than Market: Key Facts
Veeva Systems (VEEV - Free Report) closed at $316.80 in the latest trading session, marking a +2.08% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.41% for the day. Elsewhere, the Dow lost 0.07%, while the tech-heavy Nasdaq added 1.11%.
Shares of the provider of cloud-based software services for the life sciences industry witnessed a gain of 19.27% over the previous month, beating the performance of the Medical sector with its gain of 1.97%, and the S&P 500's gain of 1.46%.
Analysts and investors alike will be keeping a close eye on the performance of Veeva Systems in its upcoming earnings disclosure. In that report, analysts expect Veeva Systems to post earnings of $2.33 per share. This would mark year-over-year growth of 14.22%. Our most recent consensus estimate is calling for quarterly revenue of $933.79 million, up 15.11% from the year-ago period.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $9.22 per share and revenue of $3.69 billion. These totals would mark changes of +13.83% and +15.35%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Veeva Systems. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Veeva Systems is currently sporting a Zacks Rank of #3 (Hold).
Looking at valuation, Veeva Systems is presently trading at a Forward P/E ratio of 33.67. This expresses a premium compared to the average Forward P/E of 32.9 of its industry.
Meanwhile, VEEV's PEG ratio is currently 0.96. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The average PEG ratio for the Medical Info Systems industry stood at 3.08 at the close of the market yesterday.
The Medical Info Systems industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 96, finds itself in the top 40% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.